US 11421021
Immunogenic compositions comprising Staphylococcus aureus leukocidin LukA and LukB derived polypeptides
granted A61KA61K2039/575A61K38/00
Quick answer
US patent 11421021 (Immunogenic compositions comprising Staphylococcus aureus leukocidin LukA and LukB derived polypeptides) held by INTEGRATED BIOTHERAPEUTIC VACCINES, INC. expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- INTEGRATED BIOTHERAPEUTIC VACCINES, INC.
- Grant date
- Tue Aug 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K2039/575, A61K38/00, A61K39/085